(Q48281187)

10 February 2018

title

Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. (English)

1 reference

10 February 2018

author

Miriam Granado

1

1 reference

10 February 2018

Ana Isabel Martín

2

1 reference

10 February 2018

Asunción López-Calderón

4

1 reference

10 February 2018

author name string

Maria Angeles Villanúa

3

1 reference

10 February 2018

publication date

6 February 2007

1 reference

10 February 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

10 February 2018

volume

292

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

E1656-65

1 reference

10 February 2018

The pivotal role of cytokines in muscle wasting during cancer.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Suppression of matrix metalloproteinase production from synovial fibroblasts by meloxicam in-vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on cardiovascular alterations in endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary: a role for lipoxygenase products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Involvement of cyclooxygenase-2 in the potentiation of allyl alcohol-induced liver injury by bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Intracellular signaling during skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Prostaglandin E2 (PGE2)-induced growth hormone (GH) release: effect of intrahypothalamic and intrapituitary implants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Eicosanoid-dependent cancer cachexia and wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Arachidonic acid-induced hormone release in somatotropes: involvement of calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Evaluation of a short duration behaviour-based post-operative pain scoring system in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Mechanism of induction of muscle protein degradation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Cyclosporin a treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Biomedicine. Protein loss in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

Sulindac inhibits activation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00502.2006

10.1152/AJPENDO.00502.2006

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018